Pieris Pharmaceuticals (PIRS)
NASDAQ:PIRS
Holding PIRS?
Track your performance easily

Pieris Pharmaceuticals (PIRS) Financial Statements

592 Followers

Pieris Pharmaceuticals Financial Overview

Pieris Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-19.126; its P/E ratio is -0.89; Pieris Pharmaceuticals is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ 53.00K$ 19.52M$ 21.67M$ 2.01M
Gross Profit-$ 53.00K$ 19.52M$ 21.67M$ 1.94M
EBIT$ -3.59M$ -4.89M$ 3.09M$ 3.98M$ 19.68M
EBITDA$ -3.59M$ -4.89M$ 3.79M$ 4.73M$ 20.29M
Net Income Common Stockholders$ -3.59M$ -4.89M$ -10.75M$ 3.98M$ 19.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.73M$ 19.08M$ 44.81M$ 54.88M$ 48.38M
Total Assets$ 25.05M$ 29.50M$ 59.38M$ 87.54M$ 82.26M
Total Debt$ 0.00$ 0.00$ 12.29M$ 11.92M$ 12.20M
Net Debt$ -19.73M$ -19.08M$ -32.52M$ -42.96M$ -36.18M
Total Liabilities$ 6.35M$ 7.53M$ 28.87M$ 47.05M$ 66.80M
Stockholders Equity$ 18.70M$ 21.96M$ 30.51M$ 40.50M$ 15.46M
Cash Flow-
Free Cash Flow$ 696.00K$ -7.00M$ -9.79M$ -13.50M$ -11.04M
Operating Cash Flow$ -1.48M$ -7.00M$ -9.72M$ -13.43M$ -11.00M
Investing Cash Flow$ 2.18M$ 9.00M$ -1.98M$ -1.37M$ 11.90M
Financing Cash Flow---$ 19.78M-
Currency in USD

Pieris Pharmaceuticals Earnings and Revenue History

Pieris Pharmaceuticals Debt to Assets

Pieris Pharmaceuticals Cash Flow

Pieris Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis